Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Neither oxidized nor anti-oxidized low-density lipoprotein level is associated with atherosclerosis or mortality in hemodialysis patients.

Sevinc Ok E, Kircelli F, Asci G, Altunel E, Ertilav M, Sipahi S, Bozkurt D, Duman S, Ozkahya M, Toz H, Ok E.

Hemodial Int. 2012 Jul;16(3):334-41. doi: 10.1111/j.1542-4758.2012.00683.x. Epub 2012 Apr 13.

PMID:
22497657
2.

Role of asymmetric dimethylarginine in the progression of carotid atherosclerosis in renal transplant patients.

Cobanoglu AK, Gungor O, Kircelli F, Altunel E, Asci G, Ozbek SS, Toz H, Ok E.

Int Urol Nephrol. 2013 Oct;45(5):1463-9. doi: 10.1007/s11255-012-0345-3. Epub 2012 Dec 5.

PMID:
23212148
3.

Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.

Bossola M, Tazza L, Merki E, Giungi S, Luciani G, Miller ER, Lin EB, Tortorelli A, Tsimikas S.

Blood Purif. 2007;25(5-6):457-65. Epub 2007 Dec 13.

PMID:
18075247
4.
5.
6.

Increased levels of low-density lipoprotein oxidation in patients with familial hypercholesterolemia and in end-stage renal disease patients on hemodialysis.

Van Tits L, De Graaf J, Hak-Lemmers H, Bredie S, Demacker P, Holvoet P, Stalenhoef A.

Lab Invest. 2003 Jan;83(1):13-21.

PMID:
12533682
7.

Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.

Tsimikas S, Bergmark C, Beyer RW, Patel R, Pattison J, Miller E, Juliano J, Witztum JL.

J Am Coll Cardiol. 2003 Feb 5;41(3):360-70.

8.

Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes.

Hunt KJ, Baker N, Cleary P, Backlund JY, Lyons T, Jenkins A, Virella G, Lopes-Virella MF; DCCT/EDIC Research Group.

Atherosclerosis. 2013 Dec;231(2):315-22. doi: 10.1016/j.atherosclerosis.2013.09.027. Epub 2013 Oct 11.

9.

Oxidized low-density lipoprotein, matrix-metalloproteinase-8 and carotid atherosclerosis in spinal cord injured subjects.

Paim LR, Schreiber R, Matos-Souza JR, Silva AA, Campos LF, Azevedo ER, Alonso K, de Rossi G, Etchebehere M, Gorla JI, Cliquet A Jr, Nadruz W Jr.

Atherosclerosis. 2013 Dec;231(2):341-5. doi: 10.1016/j.atherosclerosis.2013.10.005. Epub 2013 Oct 15.

PMID:
24267248
10.

Oxidized low-density lipoproteins and their antibodies: relationships with the reverse cholesterol transport and carotid atherosclerosis in adults without cardiovascular diseases.

Ferreira PF, Zago VH, D'Alexandri FL, Panzoldo NB, Gidlund MA, Nakamura RT, Schreiber R, Parra ES, Santiago FD, Nakandakare ER, Quintão EC, de Faria EC.

Clin Chim Acta. 2012 Oct 9;413(19-20):1472-8. doi: 10.1016/j.cca.2012.05.020. Epub 2012 May 29.

11.

Oxidized LDL to autoantibodies against oxLDL ratio - the new biomarker associated with carotid atherosclerosis and cardiovascular complications in dialyzed patients.

Pawlak K, Mysliwiec M, Pawlak D.

Atherosclerosis. 2012 Sep;224(1):252-7. doi: 10.1016/j.atherosclerosis.2012.07.011. Epub 2012 Jul 16.

PMID:
22840691
12.

Short term effects of atorvastatin on endothelial functions and oxidized LDL levels in patients with type 2 diabetes.

Akalin A, Temiz G, Akcar N, Sensoy B.

Endocr J. 2008 Oct;55(5):861-6. Epub 2008 May 28.

13.

The oxidized low-density lipoprotein/β2-glycoprotein I complex is associated with abdominal obesity in healthy middle-aged men.

Kraml PJ, Syrovátka P, Potočková J, Anděl M.

Ann Nutr Metab. 2013;62(1):7-13. doi: 10.1159/000343049. Epub 2012 Nov 17.

PMID:
23171597
14.

Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.

Vuilleumier N, Charbonney E, Fontao L, Alvarez M, Turck N, Sanchez JC, Burkhard PR, Mensi N, Righini M, Reber G, James R, Mach F, Chevrolet JC, Dayer JM, Frostegard J, Roux-Lombard P.

Clin Sci (Lond). 2008 Jul;115(1):25-33.

PMID:
18088236
15.

Femoral plaques confound the association of circulating oxidized low-density lipoprotein with carotid atherosclerosis in a general population aged 35 to 55 years: the Asklepios Study.

Langlois MR, Rietzschel ER, De Buyzere ML, De Bacquer D, Bekaert S, Blaton V, De Backer GG, Gillebert TC; Asklepios Investigators.

Arterioscler Thromb Vasc Biol. 2008 Aug;28(8):1563-8. doi: 10.1161/ATVBAHA.108.167346. Epub 2008 May 29.

PMID:
18511698
16.

Carotid atherosclerosis and endothelial cell adhesion molecules as predictors of long-term outcome in chronic hemodialysis patients.

Papagianni A, Dovas S, Bantis C, Belechri AM, Kalovoulos M, Dimitriadis C, Efstratiadis G, Alexopoulos E, Memmos D.

Am J Nephrol. 2008;28(2):265-74. Epub 2007 Nov 7.

PMID:
17989499
17.

Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?

Wu T, Willett WC, Rifai N, Shai I, Manson JE, Rimm EB.

J Am Coll Cardiol. 2006 Sep 5;48(5):973-9. Epub 2006 Aug 17.

18.

Cardiovascular disease on hemodialysis: predictors of atherosclerosis and survival.

Balsam A, El Kossi MM, Lord R, El Nahas AM.

Hemodial Int. 2009 Jul;13(3):278-85. doi: 10.1111/j.1542-4758.2008.00337.x. Epub 2009 Jul 15.

PMID:
19614783
19.
20.

Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.

Mayr M, Kiechl S, Tsimikas S, Miller E, Sheldon J, Willeit J, Witztum JL, Xu Q.

J Am Coll Cardiol. 2006 Jun 20;47(12):2436-43. Epub 2006 May 30.

Supplemental Content

Support Center